Takanobu Kan

7PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Population trends and policiesChild and adolescent developmentCompound semiconductors
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
Etoposide as Late-Line Therapy for Metastatic Extramammary Paget's Disease: A Case Series.

|Dec 19, 2024
A case of malignant melanoma in which adalimumab was effective for steroid-resistant uveitis caused by dabrafenib/trametinib combination therapy.

Fumi Nakano, Takanobu Kan, Yukiko Ushio

|Mar 22, 2022
Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019.

Takanobu Kan, Akio Tanaka, Mayu Kanamoto

|Jul 28, 2021
Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan.

Akio Tanaka, Satoshi Morioke, Yukihiro Ohya

|Feb 24, 2021
Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthood.

Akio Tanaka, Satoshi Morioke, Yukihiro Ohya

|Oct 10, 2020
Calculation of practical skin donor area for meshed skin grafting in real-world surgery.

Takanobu Kan, Shunsuke Takahagi, Mikio Kawai

Pageof 2

Frequent Collaborators

7 joint publications

Akio Tanaka

5 joint publications

Shunsuke Takahagi

5 joint publications

Michihiro Hide

3 joint publications

Daiki Matsubara